7 February, 2026

‘Can’t Give Up On Korea’: What the Ghaziabad Triple Suicide...

Immunotherapy vs Chemotherapy: Which Cancer Treatment Works Better?

World Cancer Day 2026: Oncologist Warns Cervical Cancer Ignorance Is...

World Cancer Day 2026: Breast Cancer Remains the Most Common...

Home Drugs Controller General of India

Drugs Controller General of India

Nasal Covid-19 Vaccine Can Be Potential Gamechanger, Say Experts

January 10, 2021 13:31 No Comments

Can You Sue Vaccine Makers In India If You Have Severe Side Effects? Here’s What You Need To Know

January 8, 2021 10:45 No Comments

Road So Far For COVAXIN: How India’s First Domestic Coronavirus Got Approved By Drugs Experts

January 3, 2021 16:59 No Comments

CDSCO Expert Panel Seeks More Data On COVID-19 Vaccines From Serum Institute, Bharat Biotech

December 9, 2020 20:52 No Comments

Applications Of Bharat Biotech, Pfizer, Serum Institute’s Vaccine To Be Reviewed Today: Here’s What Might Happen Next

December 9, 2020 15:26 No Comments

Here’s What You Need To Know About Emergency Use Authorisation Firms Are Seeking For Covid-19 Vaccines

December 7, 2020 13:22 No Comments

A Day After Pfizer, India’s Serum Institute Seeks Emergency Use Nod For Covishield

December 7, 2020 09:09 No Comments

Recent Post

Cancer

Cancer Isn’t Just Genetics—It’s Your Lifestyle, Environment, and Stress Combined

February 7, 2026 14:31 No Comments

COVID

WHO Confirms One Nipah Virus Death in Bangladesh, Weeks After Two Cases in West Bengal

February 7, 2026 14:20 No Comments

The Nipah virus is considered one of the deadliest zoonotic infections globally, not because it spreads rapidly like influenza or COVID-19, but because of its extremely high fatality rate, rapid progression, and severe brain involvement. Medical experts warn that once symptoms escalate, the disease can turn fatal within days. According to available data, the case fatality rate of Nipah virus ranges between 50 and 75 per cent, placing it among the most lethal viral infections known to humans. In this explainer, Dr Dip Narayan Mukherjee, Consultant – Microbiology and Infectious Diseases, CK Birla Hospitals, CMRI, sheds light on why the virus is so dangerous and difficult to control. Why Is the Nipah Virus So Deadly? According to Dr Mukherjee, Nipah’s lethality lies in a combination of delayed symptom recognition, aggressive disease progression, and early involvement of the brain. “Nipah virus often begins with very non-specific symptoms, which makes early detection difficult. By the time it is clinically suspected, the virus may have already affected the brain,” he explains. Early Symptoms Often Go Unnoticed One of the biggest challenges in controlling Nipah virus is that its initial symptoms closely resemble common viral illnesses, leading to delays in diagnosis and isolation. Early symptoms include: Fever Headache Cough Muscle pain General weakness “These symptoms are easily mistaken for flu, viral fever, or respiratory infections,” says Dr Mukherjee. “This delay gives the virus time to progress silently.” Severe Brain Infection Drives High Mortality The most dangerous aspect of Nipah virus infection is its neurological involvement. The virus frequently causes encephalitis, or inflammation of the brain, which significantly increases the risk of death. Neurological symptoms may include: Seizures Confusion and altered consciousness Extreme drowsiness Coma “Once the central nervous system is involved, the disease becomes very difficult to manage,” Dr Mukherjee notes. “At this stage, treatment is largely supportive because there is no specific antiviral therapy available.” This lack of targeted treatment options makes early detection critical. Human-to-Human Transmission Raises Risk While Nipah virus is primarily transmitted from fruit bats, it can also spread from person to person, particularly in healthcare settings. Dr Mukherjee points out that: Caregivers and healthcare workers are at higher risk Exposure to high viral loads can worsen outcomes Inadequate infection control increases transmission risk “Strict adherence to infection control practices is essential. Even a small lapse can result in secondary infections,” he says. Zoonotic Nature Makes Exposure Hard to Predict Nipah virus is transmitted from fruit bats, either directly or through intermediate hosts such as pigs. This zoonotic pattern makes outbreaks unpredictable, especially in regions where humans, animals, and wildlife interact closely. Adding to the challenge: There is no approved vaccine Treatment options remain limited Isolation protocols must be strictly enforced What Can Reduce Nipah Fatalities? According to experts, early action remains the most effective defence against Nipah virus. Key measures include: Early isolation of suspected cases Strict use of personal protective equipment (PPE) Rapid escalation and referral to specialised centres Strong hospital infection control protocols “The earlier the virus is identified and contained, the better the chances of preventing severe disease and fatalities,” Dr Mukherjee emphasises. The Bottom Line Nipah virus continues to be a serious public health threat because of its high fatality rate, neurological complications, and lack of targeted treatment. Its ability to masquerade as a mild illness in the early stages makes vigilance crucial. Health experts stress that awareness, early suspicion, and strict infection control are currently the most powerful tools to reduce deaths linked to this deadly virus. As Dr Mukherjee concludes, “With Nipah, time is the most critical factor. Early recognition can save lives.”

Viral Outbreaks 2026: What Are Scientists Watching Out For?

February 7, 2026 13:52 No Comments

© Copyright 2022 Jellywp. All rights reserved powered by Jellywp.com